Miguel Ángel Sánchez-Chaparro

Author

Also Known As

M A Sanchez-Chaparro, M A Sánchez-Chaparro, M Angel Sánchez-Chaparro, M SANCHEZCHAPARRO, M. A. Sanchez-Chaparro, M. A. Sánchez-Chaparro, M. Sanchez-Chaparro, M.-A. Sanchez-Chaparro, M.-Á. Sánchez-Chaparro, M.A. Sanchez-Chaparro

Publications

668

Citations

H-Index

Concepts

All Affiliations

Universidad de Málaga Hospital Clínico Universitario Virgen de la Victoria Instituto de Investigación Biomédica de Málaga Universidade de Santiago de Compostela Hospital Universitario Virgen del Rocío

MÁ

About

Miguel Ángel Sánchez-Chaparro is an author at Universidad de Málaga specializing in metabolic syndrome, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	144
2	Diabetes	4	4	101
3	Epidemiology	4	4	132
4	Public Health	3	3	119
5	Health Sciences	1	1	13

Miguel Ángel Sánchez-Chaparro

Publications

360

Citations

H-Index

Page 1

	Year	Citations
Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: Results of the ICARIA study Pedro Valdivielso, Miguel Ángel Sánchez-Chaparro, Eva Calvo‐Bonacho, Atherosclerosis ObesityMetabolic SyndromeSevere HypertriglyceridemiaVascular DiseaseDiabetes Epidemiology	2009	48
The relationship between job stress and dyslipidemia C. Catalina-Romero, E. Calvo, Miguel Ángel Sánchez-Chaparro, Scandinavian Journal of Public Health	2013	47
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society María José Ariza, José Rioja, Daiana Ibarretxe, Journal of clinical lipidology Metabolic SyndromeFamilial Chylomicronemia SyndromeEpidemiologyLipid DisorderCardiovascular Disease	2018	43
COVID-19 and Sick Leave: An Analysis of the Ibermutua Cohort of Over 1,651,305 Spanish Workers in the First Trimester of 2020 Eva Calvo‐Bonacho, C. Catalina-Romero, Carlos Fernández-Labandera, Frontiers in Public Health	2020	41
Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum Ana María Sánchez‐Tévar, María García‐Fernández, Belén Murcia-Casas, Annals of Translational Medicine	2019	35
Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: A study in patients with type 2 diabetes and controls Pedro Valdivielso, S. Puerta, José Rioja, Clinica Chimica Acta Metabolic SyndromeVascular DiseaseCardiovascular DiseaseDiabetesPeripheral Artery Disease	2010	28
Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study E. Calvo-Bonacho, Luís M. Ruilope, Miguel Ángel Sánchez-Chaparro, European Heart Journal	2013	26
High risk of subclinical atherosclerosis in COPD exacerbator phenotype Adolfo Doménech, Ana Muñoz-Montiel, Natalia García‐Casares, Respiratory Medicine	2018	15
Factors influencing return-to-work after cerebrovascular disease: the importance of previous cardiovascular risk C. Catalina-Romero, Luís M. Ruilope, Miguel Ángel Sánchez-Chaparro, European Journal of Preventive Cardiology	2014	14
Prediction of fatal and non-fatal cardiovascular events in young and middle-aged healthy workers: The IberScore model Carlos Fernández-Labandera, Eva Calvo‐Bonacho, Pedro Valdivielso, European Journal of Preventive Cardiology	2019	14

Page 1